Pralidoxime Chloride/Benactyzine Hydrochloride/Atropine Sulfate

氯解磷定/盐酸贝那替秦/硫酸阿托品

Report date: 2022/02/18 15:13:31

Base Information

Drug NamePralidoxime Chloride/Benactyzine Hydrochloride/Atropine Sulfate
Drug Alias Name复方氯解磷定注射液
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcetylcholinesterase activatorsMuscarinic acetylcholine receptor antagonists
TargetsAcetylcholinesteraseMuscarinic acetylcholine receptor
Therapy Area/IndicationsPoisoning
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes Pralidoxime ChlorideBenactyzine HydrochlorideAtropine Sulfate
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsPoisoning
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A